Skip to main content Skip to main navigation menu Skip to site footer

Profil pasien COVID-19 rawat inap di Rumah Sakit Ari Canti, Gianyar, Bali, Indonesia


Background: Since March 2020, Coronavirus Disease 2019 (COVID-19) has been declared a pandemic. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) underwent genetic evolution and changes in the nature of the virus, clinical manifestations, and response to treatment. This study aims to determine the profile of hospitalized COVID-19 patients at  Ari Canti Hospital (RSAC), one of the COVID-19 referral hospitals in Gianyar, Bali.

Methods: The design was a descriptive cross-sectional retrospective study, using the medical records of confirmed COVID-19 by Real Time Polymerase Chain Reaction (RT-PCR) patients selected by a simple random sampling technique.

Results: From 290 samples, the majority of COVID-19 patients treated at RSAC were 60.7% male, in the age range of 50-59 years 26.5%, with severe symptoms 45.8% and recovered 83.4%. The dominant symptoms were fever 85.2%, cough 80%, and shortness of breath 60%. The most common comorbidities were >1 comorbidity, hypertension, and diabetes mellitus. Hematological examination at the first time of hospitalization showed leukopenia (4.8%), lymphopenia (14.5%), thrombocytopenia (12.8%),  and anemia (21.7%). The results also showed an increase in Neutrophil to Lymphocyte ratio (NLR) (31.4%), Platelet to lymphocyte ratio (PLR) (11.7%), Red Cell Distribution Width (RDW) (40.7%), D-Dimer  (73.4% ) dan High sensivity C-Reactive Protein (Hs-CRP)  (66.6%). Most showed bilateral infiltrates on chest x-ray. The most common treatment for COVID-19 at RSAC uses antiviral remdesivir (77.9%), quinolone antibiotics (73.4%), and Low Molecular Weight Heparin (LMWH) (53.4%).  A total of 56.6% of patients received corticosteroid therapy.

Conclusion: Patients hospitalized at RSAC mostly showed severe symptoms and recovered. The treament folowing the standard of inpatient treatment for COVID-19 patients.


Latar belakang: Sejak Maret 2020, Coronavirus Disease 2019 (COVID 19) dinyatakan sebagai pandemi. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mengalami evolusi genetik dan perubahan sifat virus, manifestasi klinis serta respon pengobatan. Penelitian ini bertujuan untuk mengetahui profil pasien COVID-19 yang dirawat di Rumah Sakit Ari Canti (RSAC), salah satu rumah sakit rujukan COVID-19 di Gianyar, Bali

Metode: Rancangan penelitian ini adalah cross-sectional deskriptif retrospektif, menggunakan rekam medis pasien terkonfirmasi COVID-19 dengan Real Time Polymerase Chain Reaction (RT-PCR) sejak Juli 2020 - Maret 2022 yang dipilih dengan teknik simple random sampling.

Hasil: Dari 290 sampel, mayoritas pasien COVID-19 yang dirawat di RSAC adalah laki-laki 60.7%, berada pada rentang usia 50-59 tahun 26.5%, dengan gejala berat 45.8% dan sembuh 83.4%. Gejala didominasi demam 85.2%, batuk 80%, dan sesak 60%. Komorbid tersering yaitu >1 komorbid, hipertensi, dan diabetes melitus. Gambaran hematologi menunjukkan leukopenia (4.8%), limfopenia (14.5%), trombositopenia (12.8%), dan  anemia (21.7%). Hasil juga menunjukkan peningkatan Neutrophil to Lymphocyte ratio (NLR) (31.4%), Platelet to lymphocyte ratio (PLR) (11.7%), Red Cell Distribution Width (RDW) (40.7%), D-Dimer (73.4% ) dan High sensivity C-Reactive Protein (Hs-CRP) (66.6%). Sebagian besar menunjukkan infiltrat bilateral pada x-ray thorax. Tatalaksana COVID-19 di RSAC tersering menggunakan antivirus remdesivir (77.9%), antibiotik golongan kuinolon (73.4%), dan antikoagulan Low Molecule Weight Heparin (LMWH) (53.4%). Sebanyak 56.6 % pasien mendapat terapi kortikosteroid.

Kesimpulan: Pasien COVID-19 yang dirawat di RSAC sebagian besar menunjukkan gejala berat dan sembuh. Terapi yang diberikan mengikuti standar terapi rawat inap pasien COVID-19.


  1. Prabawa IMY, Silakarma D, Prabawa IPY, Manuaba IBAP. Physical Rehabilitation Therapy for Long COVID-19 Patient with Respiratory Sequelae: A Systematic Review. Open Access Maced J Med Sci. 2022;10(F):468-74.
  2. Herawati S, Kandarini Y, Mulyantari NK, Prabawa IPY. Correlation of Neutrophil to Lymphocyte Ratio with Interleukin-10 in Diagnosis and Monitoring of Coronavirus Disease-19 Patients. Open Access Maced J Med Sci. 2022;10(B):63-6.
  3. Elisabetta C, John EB, Laura ER. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature 2022;602;664-670.
  4. Parwanto MLE, Digambiro RA, Nusantara DU, Rarasati T. Coronavirus disease 2019 (COVID-19): A case report in a patient with diabetic ketoacidosis and hypertension. Bali Medical Journal. 2020;9(3):624-629.
  5. Beyerstedt S, Casarol EB, Rangel EB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40:905–919.
  6. Hsieh PP, Kristian H, Permana AJM, Wongsodiharjo M, Nugraheni PA, Charisti P, Diarsvitri W. The clinical pictures of COVID-19 pediatric patients in dr. R. Soedarsono Regional General Hospital, Pasuruan, East Java, Indonesia. Bali Medical Journal. 2022;11(1):460-465.
  7. Henry BM, Benoit JL, Benoit S, Pulvino C, Berger BA, de Olivera MHS. Red Blood Cell Distribution Width (RDW) Predicts COVID-19 Severity: A Prospective, Observational Study From the Cincinnati SARS- CoV-2 Emergency Department Cohort. Diagnostics. 2020;10(9):1–9.
  8. Nurhidayati T, Sari SR, Soesanto E, Setyawati D. The Influence of health education about covid-19 on posbindu participants’ knowledge levels at Puskesmas Gesi. Bali Medical Journal 2021;10(3):1216-1219.
  9. Indra B, Lipoeto NI, Hardisman H, Putra AE, Tjong DH, Rahman S, Yusri E, Bilhaq MR, Pratama Y, Risman Y. The Severity of COVID-19 and its Correlation with Inflammation Biomarkers. Open Access Maced J Med Sci. 2022;10(A):911-5.
  10. Langford B, So M, Raybardhan S, Leung V, Soucy JR, Westwood D. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clinical Microbiology and Infection. 2021;27:520-531.
  11. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693-704.
  12. Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D. Clinical Characteristics Of Laboratory Confirmed Positive Cases Of SARS-CoV-2 Infection In Wuhan, China: A Retrospective Single Center Analysis. Travel Med Infect Dis. 2020;36:1–3.
  13. Lopes RD, Macedo AVS, Silva PD, Moll-Bernardes RJ, Santos TM, Mazza L. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19 A Randomized Clinical Trial. JAMA. 2021;325( 3):254-264.
  14. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019- nCoV infection. Frontiers of Medicine. 2021;14:185–192.
  15. Peng J, Qi1 D, Yuan G, Deng X, Mei Y, Feng L. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, crosssectional Study. J Clin Lab Anal. 2020;34:e23475
  16. Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao S. Association Between Platelet Parameters And Mortality In Coronavirus Disease 2019: Retrospective Cohort Study. Platelets. 2020;31(4):490–6.
  17. Nugrahaningsih DAA, Purnomo E, Siswanto, Reviono, Yasmina A, Prenggono MD, Fajari NM, Rudiansyah M, Harsini, Syarif RA, Sholikah, EN. Features of COVID-19 adult patients and the treatment in Indonesia: a retrospective cohort study. Bali Medical Journal. 2022;11(1):528-539.
  18. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021; 384(8):693-704.
  19. Ranjbar K, Moghadami M, Mirahmadizadeh A, Fallahi MJ, Shahriarirad KVR, Erfani A. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infectious Diseases. 2021;21:337.
  20. Surendraa H, Elyazara IRF, Djaafaraa BA, Ekawatia LL, Saraswatia K, Adrian V. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. The Lancet Regional Health Western Pacific. 2021;9:100-108.

How to Cite

Wiryandari, N. P. N., & Suardamana, K. (2022). Profil pasien COVID-19 rawat inap di Rumah Sakit Ari Canti, Gianyar, Bali, Indonesia. Intisari Sains Medis, 13(3), 684–689.




Search Panel

Ni Putu Nita Wiryandari
Google Scholar
ISM Journal

Ketut Suardamana
Google Scholar
ISM Journal